BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18384426)

  • 1. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
    Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
    Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
    Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
    Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers.
    Offit K; Gilad S; Paglin S; Kolachana P; Roisman LC; Nafa K; Yeugelewitz V; Gonzales M; Robson M; McDermott D; Pierce HH; Kauff ND; Einat P; Jhanwar S; Satagopan JM; Oddoux C; Ellis N; Skaliter R; Yahalom J
    Clin Cancer Res; 2002 Dec; 8(12):3813-9. PubMed ID: 12473594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.
    Cavaciuti E; Laugé A; Janin N; Ossian K; Hall J; Stoppa-Lyonnet D; Andrieu N
    Genes Chromosomes Cancer; 2005 Jan; 42(1):1-9. PubMed ID: 15390180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
    Kontorovich T; Cohen Y; Nir U; Friedman E
    Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two ATM variants and breast cancer risk.
    Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of ATM mutations to familial breast and ovarian cancer.
    Thorstenson YR; Roxas A; Kroiss R; Jenkins MA; Yu KM; Bachrich T; Muhr D; Wayne TL; Chu G; Davis RW; Wagner TM; Oefner PJ
    Cancer Res; 2003 Jun; 63(12):3325-33. PubMed ID: 12810666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM variants and cancer risk in breast cancer patients from Southern Finland.
    Tommiska J; Jansen L; Kilpivaara O; Edvardsen H; Kristensen V; Tamminen A; Aittomäki K; Blomqvist C; Børresen-Dale AL; Nevanlinna H
    BMC Cancer; 2006 Aug; 6():209. PubMed ID: 16914028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
    Tapia T; Sanchez A; Vallejos M; Alvarez C; Moraga M; Smalley S; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2008 Jan; 107(2):281-8. PubMed ID: 17351744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
    Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
    Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary breast cancer: from molecular pathology to tailored therapies.
    Tan DS; Marchiò C; Reis-Filho JS
    J Clin Pathol; 2008 Oct; 61(10):1073-82. PubMed ID: 18682420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
    Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
    Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.